clinical research laboratory News
-
Merck Receives Positive EU CHMP Opinion for Updated Label of KEYTRUDA® (pembrolizumab) To Include Results of Phase 3 KEYNOTE-361 Trial in Certain Adult Patients with Locally Advanced or Metastatic Urothelial Cancer
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that the European label for KEYTRUDA, Merck’s anti-PD-1 therapy, be updated to include data from KEYNOTE-361, a Phase 3, open-label trial that evaluated KEYTRUDA ...
-
Join Us in Atlanta with Our Complimentary Clinical Expo Badge
Despite the challenges, our global laboratory community is more united and determined than ever. The in-person is now possible again. And we can’t wait to meet you in Atlanta! Claim your complimentary Clinical Lab Expo pass and join your community for clinical laboratory science education, problem-solving and networking at the 2021AACC Annual Scientific Meeting & Clinical Lab Expo. ...
-
AptaMatrix, Inc. Receives a NIH Small Business Innovation Research Phase II Award
AptaMatrix, Inc., a Syracuse-based biotech company focused on developing aptamer-based technologies for diagnostic applications, announces that it has been awarded a $2M Phase II Small Business Innovation Research (SBIR) grant by the National Institute of General Medical Sciences (NIGMS) institute of the National Institutes of Health (NIH). The Phase II award will allow AptaMatrix to develop and ...
-
Thermo Fisher Scientific Announces Collaboration to Develop Advanced Analytical Workflows for Clinical Laboratories
Thermo Fisher Scientific, the world leader in serving science, and Cedars-Sinai, a leading nonprofit academic healthcare organization, have entered into a collaboration to develop a pathway to precision medicine through the development of robust, reliable and sensitive liquid chromatography mass spectrometry (LC-MS)-based workflows for clinical research applications. Bringing together Thermo ...
-
Bio-Techne and Hall of Famer Cal Ripken Jr -Announce Partnership to Raise Awareness and Education to Empower Men With Prostate Cancer
Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with Hall of Famer and baseball's all-time "Iron Man", Cal Ripken Jr. This year marks 25 years since Ripken played in his 2,131st consecutive game, eclipsing the thought to be unbreakable record of 2,130 set by the legendary Lou Gehrig. Recently the 21-year Major ...
-
Agilent Technologies expands next-generation sequencing target-enrichment platform with SureCall Software upgrade
Agilent Technologies Inc. (NYSE: A) today introduced SureCall version 2.0 software, expanding the capabilities of the company's current market-leading, next-generation sequencing target-enrichment solutions. The newly upgraded software features compatibility with SureSelect custom target-enrichment and Human All Exon panels. One of the biggest challenges faced by clinical research labs when ...
-
Lauren Sciences LLC research team at Ben-Gurion University successfully completes Campbell Foundation 1-year grant to develop V-Smart therapeutic for neuro-HIV
New York, N.Y., October 22, 2013 -- Lauren Sciences LLC, a privately-held biotechnology company furthering development of V-Smart™ therapeutics based upon its novel nanovesicle platform technology, announced today successful completion by its research team at Ben-Gurion University of the first stage of developing a V-Smart™ therapeutic for the treatment of neuro-HIV. The development ...
-
Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization
Establishes Thermo Fisher as a global leader in the attractive and high growth clinical research services industry Adds highly complementary services for the company's fastest growing end market Offers both meaningful cost and revenue synergies which will further accelerate growth Expected to be immediately and significantly accretive to Adjusted Earnings Per Share (EPS)¹ after close ...
-
Thermo Fisher Scientific Opens Call for Grant Proposals to Fund Clinical Research in Hematology-oncology
To support clinical research needs using next-generation sequencing (NGS), Thermo Fisher Scientific today announced it is accepting new submissions for its Oncomine Clinical Research Grant. The latest call for proposals aims to provide funding for clinical research programs that leverage NGS in solid tumors and hematology-oncology applications. The Oncomine Clinical Research Grant awards ...
-
Arterius Welcomes New Clinical Advisers
Arterius are pleased to welcome Prof. Patrick Serruys and Dr. Yoshi Onuma to our clinical advisory board. Prof. Serruys (Imperial College, London) will become chair of the clinical advisory board, also now featuring Dr. Onuma (Cardialysis, Netherlands) and Dr. Rasha Al-Lamee (Imperial College, London). Prof. Patrick W. Serruys is is a professor of Interventional Cardiology at the ...
-
Training and consultancy for Analyse-it
Our focus at Analyse-it has always been on the development and improvement of our software. While we provide extensive help, tutorials, and technical support for Analyse-it, one area we do not cover is training and consultancy. As many of you will know we are based in England in the United Kingdom, and providing training and consultancy is often done better locally, in-person. Instead we ...
-
Molecular Health and Gen Era Diagnostics agree to collaborate in the field of precision oncology in Turkey
Molecular Health and the life science company Gen Era Diagnostics have signed a collaboration agreement to optimize the personalized treatment of patients with cancer. For this purpose, Gen Era will provide the MH Guide software platform to twenty laboratories in Turkey to use in the interpretation of tumor data. “We are pleased to have Molecular Health on board in the near future as an ...
-
ECCMID 2020 Alert: Selux Diagnostics Hosting Integrated Symposium at 30th European Congress of Clinical Microbiology & Infectious Diseases
Selux Diagnostics, Inc., which is leading a new era in personalized medicine to treat superbug infections and combat antimicrobial resistance, today announced it will host an integrated symposium on aspects that impact antimicrobial resistance, rapid diagnostics and clinical care at this spring's 2020 European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Paris, France. ...
-
PixCell Medical and Gamidor Diagnostics Partner to Introduce Point-of-Care Hematology Analysis in Israelq
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, today announced it has signed an exclusive distribution agreement with medical diagnostics company Gamidor Diagnostics to distribute the HemoScreen™, PixCell's hematology analyzer, across Israel. This deal follows a global shift spurred by the COVID-19 pandemic towards near-patient, digitally connected testing ...
-
Darryl C. Zeldin named National Institute of Environmental Health Sciences scientific director
The National Institute of Environmental Health Sciences (NIEHS), which is part of the National Institutes of Health (NIH), is pleased to announce that physician-scientist Darryl C. Zeldin, M.D., will become the institute’s new scientific director. Effective Oct. 23, Zeldin will lead and manage a $114 million biomedical research program focused on discovering how the environment influences ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you